Sino Biological and Rapid Novor Partner to Offer Combined Sequencing and Antibody Development Services
BEIJING, China, March 14, 2024 (GLOBE NEWSWIRE) – via NewMediaWire – Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the ChiNext subsidiary of the Shenzhen Stock Exchange (SZSE: 301047), which supplies reagents for biological studies and related contracted technical studies. Array is pleased to announce the formation of a partnership with Rapid Novor, Inc. , founded in Toronto, Canada (“Rapid Novor”). Under the terms of the agreement, Sino Biological will commercialize Novor’s proprietary REmAb de novo monoclonal antibody (mAb) sequencing service in combination with its custom-designed mAb production and progression array. Geographic spaces covered through this partnership include China, Singapore, Thailand, Malaysia, Indonesia, Vietnam, the Philippines, Japan, and South Korea.
Headquartered in Beijing, China, Sino Biological is the world’s leading supplier of recombinant mammalian cell-based proteins, antibodies, and related contract study facilities. A significant portion of its custom-designed contract studio facilities involve the design, expansion, and production of custom-designed monoclonals. antibodies for fundamental studies and in vitro diagnostic applications. The combination of providing consumers with data on the nucleic acid and amino acid series of the monoclonal antibody active site, as well as the corresponding purified bioactive antibody, will provide consumers with invaluable design data. and serve as antibodies, enabling consumers to optimize antibody engineering strategies, protect intellectual properties, and expand new diagnostic and drug discovery platforms.
“A built-in solution that combines reliable protein sequencing and recombinant expression provides scientists with a practical way to comprehensively understand and produce useful antibodies,” said Iain Rogers, vice president of advertising at Rapid Novor. “We are excited that Sino Biological consumers now have access to accurately sequence our REmAb technology. “
About Sino BiologicalSino Biological is a foreign supplier of reagents and contract studiesArray’s company specializes in the production of recombinant proteins and antibody progression. All of Sino Biobiotic’s products are independently developed and produced with a rigorous quality control formula and come with proprietary bioreagents that address spaces such as mobile therapy, stem cells, and infectious disease studies. For example, Sino Biological offers the widest variety of viral antigens (Provir®) and corresponding antibodies in the world. Sino Biological is also a qualified and identified source of high-quality, GMP-grade recombinant cytokines and cytokines. In addition, Sino Biological offers contract study production for the custom-designed progression of complete bioactive proteins and high-affinity antibodies, as well as other arrays. To learn more about Sino Biological, stop by www. sinobiological. com, stay with us on LinkedIn or @SinoInc on Twitter.
About Rapid NovorRapid Novor Inc. es the world leader in the generation of antibody protein sequencing. Specializing in the field of mass spectrometry-based proteomics, the team has evolved generation for direct series of antibody proteins without the need to access the mobile generation line. Located in the Kitchener-Waterloo high-tech hub, the company continues to expand its generation portfolio based on years of clinical studies and inventions. The company’s vision is to improve human fitness by interpreting immunity. For more information, visit https://www. rapidnovor. com. Suivez @rapidnovor on X (formerly Twitter) or LinkedIn.
Forward-Looking Statements
Contacts:
gmo@sinobiological. cn
pr@rapidnovor. com